On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Thomas J. Lynch

ResearcherPublications, citations & collaboration network

Thomas J. Lynch is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Thomas J. Lynch have?

ScholarIQindexed works

Thomas J. Lynch has 399 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Thomas J. Lynch have?

ScholarIQcitation count

Thomas J. Lynch has 56,140 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Thomas J. Lynch?

ScholarIQh-index

Thomas J. Lynch has an h-index of 84 in OpenAlex.

What is the i10-index of Thomas J. Lynch?

ScholarIQi10-index

Thomas J. Lynch has an i10-index of 231 in OpenAlex.

What is the ORCID of Thomas J. Lynch?

ScholarIQorcid

The ORCID for Thomas J. Lynch is on the source record.

What is the OpenAlex record for Thomas J. Lynch?

ScholarIQopenalex

The OpenAlex for Thomas J. Lynch is on the source record.

What are the most-cited papers on Thomas J. Lynch?

ScholarIQmost cited works
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Jennifer S. Temel, Joseph A. Greer, Alona Muzikansky, Emily R. Gallagher, Sonal Admane, Vicki A. Jackson, Constance Dahlin, Craig D. Blinderman, Juliet Jacobsen, William F. Pirl, J. Andrew Billings, Thomas J. Lynch
New England Journal of Medicine. 20107,489 Citations
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate
New England Journal of Medicine. 20104,513 Citations
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman
Science Translational Medicine. 20113,582 CitationsOPEN ACCESS
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>
Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate
Journal of Clinical Oncology. 20091,889 CitationsOPEN ACCESS
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian W. Brannigan, Chey V. Collura, Elizabeth K. Inserra, Sven Diederichs, A. John Iafrate, Daphne W. Bell, Subba R. Digumarthy, Alona Muzikansky, Daniel Irimia, Jeffrey Settleman, Ronald G. Tompkins, Thomas J. Lynch, Mehmet Toner, Daniel A. Haber
New England Journal of Medicine. 20081,615 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account